this stage. Key documents include:

• Validation Master Plan (VMP)
• User Requirements Specification (URS)
• Functional Specification (FS)
• Risk Assessment Documentation

Roles involved typically include quality assurance (QA) professionals, IT personnel, and system users. During inspections, regulatory authorities will expect to see evidence of a robust validation process, including documented user requirements and risk assessments.

For example, a pharmaceutical company implementing a new laboratory information management system (LIMS) must first define what the system is expected to do. This includes specifying how data will be captured, stored, and reported, ensuring compliance with regulations such as 21 CFR Part 11.

Step 2: Conducting a Gap Analysis

The next phase involves conducting a gap analysis to identify discrepancies between current practices and regulatory requirements. The objective is to pinpoint areas needing improvement before formal validation begins.

Documentation for this step should include:

• Current State Assessment Report
• Gap Analysis Report
• Action Plan for Remediation

Roles involved in this analysis typically include compliance officers, IT specialists, and project managers. During inspections, authorities will look for a clear understanding of existing gaps and a plan for addressing them.

For instance, if a company’s existing electronic records system does not meet the requirements for audit trails as outlined in 21 CFR Part 11, this gap must be documented and addressed in the action plan.

Step 3: Developing a Validation Strategy

Once gaps have been identified, the next step is to develop a comprehensive validation strategy. The objective is to create a structured approach to validating the computerized system that aligns with regulatory expectations.

Documentation should include:

• Validation Strategy Document
• Test Plans
• Validation Protocols

Key roles in this phase include validation engineers, QA personnel, and project stakeholders. Inspectors will expect to see a validation strategy that outlines the approach, methodologies, and tools to be used throughout the validation process.

For example, a biotech firm planning to validate a new manufacturing execution system (MES) would detail how they intend to conduct installation qualification (IQ), operational qualification (OQ), and performance qualification (PQ) testing.

Step 4: Executing the Validation Plan

With a validation strategy in place, the next phase is executing the validation plan. The objective is to perform the actual testing of the computerized system to ensure it meets all specified requirements.

Documentation during this phase should include:

• Execution Records
• Test Results
• Deviations and CAPA Records

Roles involved typically include validation teams, system users, and QA reviewers. Regulatory inspectors will expect to see comprehensive execution records that demonstrate adherence to the validation plan.

For instance, if a medical device company is validating a software application for device control, they must execute the test cases outlined in the validation protocol and document all results, including any deviations and corrective actions taken.

Step 5: Documenting the Validation Results

After executing the validation plan, the next step is to document the validation results comprehensively. The objective is to provide a clear record of the validation process and its outcomes.

Key documentation should include:

• Validation Summary Report
• Final Validation Report
• Change Control Documentation

Roles involved in this documentation phase include validation specialists, QA personnel, and regulatory affairs teams. During inspections, authorities will look for a complete and accurate record of validation activities and results.

For example, a pharmaceutical company must compile a validation summary report that includes all test results, deviations, and the final assessment of whether the system is fit for its intended use.

Step 6: Maintaining Compliance Through Ongoing Monitoring

The final step in the readiness assessment process is establishing a framework for ongoing monitoring and maintenance of the validated system. The objective is to ensure continued compliance with regulatory requirements and internal quality standards.

Documentation for this phase should include:

• Change Management Procedures
• Periodic Review Plans
• Training Records

Roles involved typically include compliance officers, IT support, and QA teams. Inspectors will expect to see a robust system for monitoring changes and ensuring that any modifications to the computerized system do not compromise its validated state.

For instance, if a company updates its eQMS software, it must conduct a re-validation or impact assessment to ensure that the changes do not affect compliance with 21 CFR Part 11.

Conclusion

Conducting a computerized system validation readiness assessment is a critical process for organizations in regulated industries. By following the outlined steps—understanding validation, conducting a gap analysis, developing a validation strategy, executing the plan, documenting results, and maintaining compliance—organizations can ensure that their computerized systems meet regulatory expectations and support their quality management systems effectively.

For more detailed guidance on computerized system validation, refer to the FDA’s [Guidance for Industry on Computerized Systems Used in Clinical Investigations](https://www.fda.gov/media/116716/download) and the ISO 9001 standards for quality management systems.